Pharmacokinetics and pharmacodynamics of xylazine administered by the intravenous or intra-osseous route in adult horses.

The research investigated the pharmacokinetics and pharmacodynamics of xylazine in horses, comparing its administration via both intravenous and intra-osseous methods. The study found that both methods provided similar outcomes in terms of sedation levels and no complications were observed from the intra-osseous device placement.

Objective and Methodology of the Study

• The primary objective of this research was to compare intravenous (i.v.) and intra-osseous (IO) administration of the sedative xylazine in adult horses. The researchers sought to identify whether the IO route could be a safe and effective alternative to the conventional i.v. route, especially in situations where i.v. administration is impractical or contraindicated.
• A total of six adult horses were included in the study, with xylazine administered either i.v. or IO in a blocked-randomized crossover design.
• For the i.v. trial, both jugular veins in the horses were catheterized, one for drug administration and the other for blood collection. For the IO trial, only one jugular vein was catheterized for blood collection, and the xylazine was administered using an intra-osseous device placed in the tuber coxae (hip bone).

Measured Variables and Analytical Methods

• The researchers tracked variables such as heart rate, respiratory rate, head position, and concentration of sedation at different time intervals up to 90 minutes following administration.
• Xylazine concentrations in the blood were measured using high-performance liquid chromatography, a technique frequently used in biochemistry and molecular biology to identify and measure compounds. Subsequently, a noncompartmental analysis was conducted, a pharmacokinetic method aiming to establish the exposure to a drug after administration.
• In terms of statistical methods, the researchers used general linear mixed modeling (a statistical technique that accounts for both fixed and random effects) and Wilcoxon signed-rank tests, a nonparametric statistical hypothesis test used when comparing two related samples.

Findings of the Study

• The study did not identify any significant differences in the heart rate, respiratory rate, head position, concentration of sedation, peak concentration (Cmax), the time to reach peak concentration (Tmax), half-life, or the area under the curve (AUC, a measure of the drug exposure over time) between the i.v. and the IO routes of drug administration.
• Importantly, no complications were observed following the placement of the intra-osseous device, suggesting this form of administration could be a viable option in situations where i.v. access is challenging.

Implications of the Study

• Based on the findings of the research, the IO administration of xylazine offers a useful alternative to i.v. administration in emergent situations or where i.v. access is difficult or contraindicated for other reasons. This could open up new opportunities in veterinary medicine for effective sedative administration.